Andrea Necchi
Andrea Necchi/LinkedIn

Andrea Necchi: The Latest Findings From Sunrise4 Trial

Andrea Necchi, Associate Editor at Journal of Clinical Oncology, shared on X:

“I enjoyed a conversation with The Lancet Oncology Senior Editor Smriti Patodia on our latest findings from Sunrise4 trial (neoadjuvant TAR200+cetrelimab vs cetrelimab in pts with MIBC). Primary analysis with ctDNA/utDNA results are awaited.”

More from Andrea Necchi on OncoDaily.